Cannabinoid-induced hyperphagia: Correlation with inhibition of proopiomelanocortin neurons?

Physiology and Behavior

Volumn 92, Issue 3, 2007, Pages 507-519

  Ho, Jennie ^a   Cox, Jeremy M ^a   Wagner, Edward J ^a  

^a Western University of Health Sciences   (United States)

Author keywords

Arcuate; CB1 receptor; Electrophysiology; Feeding; Glutamate; POMC; Potassium conductance

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID; PROOPIOMELANOCORTIN;

ANIMAL MODEL; ARCUATE NUCLEUS; ARTICLE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; FEEDING BEHAVIOR; FOOD INTAKE; HYPERPHAGIA; MALE; NONHUMAN; PATCH CLAMP; POTASSIUM CONDUCTANCE; PRIORITY JOURNAL; WEIGHT REDUCTION;

EID: 35248863399     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2007.04.028     Document Type: Article

References (66)

1. 9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine. Pharmacol Biochem Behav 71 (2002) 341-348
2. Berry E.M., and Mechoulam R. Tetrahydrocannabinol and endocannabinoids in feeding and appetite. Pharmacol Ther 95 (2002) 185-190
3. 9-tetrahydrocannabinol and marijuana in humans. Psychopharmacology (Berl) 161 (2002) 331-339
4. Cota D., Marsicano G., Lutz B., Vicennati V., Stalla G.K., Pasquali R., et al. Endogenous cannabinoid system as a modulator of food intake. Int J Obes 27 (2003) 289-301
5. Fride E., Bregman T., and Kirkham T.C. Endocannabinoids and food intake: newborn suckling and appetite regulation in adulthood. Exp Biol Med 230 (2005) 225-234
6. Inui A. Cancer anorexia-cachexia syndrome: current issues in research and management. CA Cancer J Clin 52 (2002) 72-91
7. Woolridge E., Barton S., Samuel J., Osorio J., Dougherty A., and Holdcroft A. Cannabis use in HIV for pain and other medical symptoms. J Pain Symptom Manage 29 (2005) 358-367
8. Hildebrandt A.L., Kelly-Sullivan D.M., and Black S.C. Antiobesity effects of chronic CB1 receptor antagonist treatment in diet-induced obese mice. Eur J Pharmacol 462 (2003) 125-132
9. Cani P.D., Montoya M.L., Neyrinck A.M., Delzenne N.M., and Lambert D.M. Potential modulation of plasma ghrelin and glucagon-like peptide-1 by anorexigenic cannabinoid compounds, SR141716A (rimonabant) and oleoylethanolamide. Br J Nutr 92 (2004) 757-761
10. Wierzbicki A.S. Rimonabant: endocannabinoid inhibition for the metabolic syndrome. Int J Clin Pract 60 (2006) 1697-1706
11. 1 receptor immunoreactivity in the guinea pig and rat myenteric plexus. J Comp Neurol 448 (2002) 410-422
12. Pertwee R.G. Cannabinoids and the gastrointestinal tract. Gut 48 (2001) 859-867
13. Burdyga G., Lal S., Varro A., Dimaline R., Thompson D.G., and Dockray G.J. Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin. J Neurosci 24 (2004) 2708-2715
14. Derbenev A.V., Stuart T.C., and Smith B.N. Cannabinoids suppress synaptic input to neurones of the rat dorsal motor nucleus of the vagus nerve. Physiology 559 (2004) 923-938
15. Edwards C.M.B., Abusnana S., Sunter D., Murphy K.G., Ghatei M.A., and Bloom S.R. The effect of the orexins on food intake: comparison with neuropeptide Y, melanin-concentrating hormone and galanin. J Endocrinol 160 (1999) R7-R12
16. Ballinger A.B., Williams G., Corder R., El-Haj T., and Farthing M.J.G. Role of hypothalamic neuropeptide Y and orexigenic peptides in anorexia associated with experimental colitis in the rat. Clin Sci 100 (2001) 221-229
17. Della-Zuana O., Presse F., Ortola C., Duhault J., Nahon J.L., and Levens N. Acute and chronic administration of melanin-concentrating hormone enhances food intake and body weight in Wistar and Sprague-Dawley rats. Int J Obes 26 (2002) 1289-1295
18. Abbott C.R., Kennedy A.R., Wren A.M., Rossi M., Murphy K.G., Seal L.J., et al. Identification of hypothalamic nuclei involved in the orexigenic effect of melanin-concentrating hormone. Endocrinology 144 (2003) 3943-3949
19. Kotz C.M., Grace M.K., Briggs J.E., Billington C.J., and Levine A.S. Naltrexone induces arcuate nucleus neuropeptide Y gene expression in the rat. Am J Physiol Regul Integr Comp Physiol 271 (1996) R289-R294
20. Glaum S.R., Hara M., Bindokas V.P., Lee C.C., Polonsky K.S., Bell G.I., et al. Leptin, the obese gene product, rapidly modulates synaptic transmission in the hypothalamus. Mol Pharmacol 50 (1996) 230-235
21. Kalra S.P., and Horvath T.L. Neuroendocrine interactions between galanin, opioids and neuropeptide Y in the control of reproduction and appetite. Ann N Y Acad Sci 863 (1998) 236-240
22. Smith M.S., and Grove K.L. Integration of the regulation of reproductive function and energy balance: lactation as a model. Front Neuroendocrinol 23 (2002) 225-256
23. Toshinai K., Date Y., Murakami N., Shimada M., Mondal M.S., Shimbara T., et al. Ghrelin-induced food intake is mediated via the orexin pathway. Endocrinology 144 (2003) 1506-1512
24. Varma M., Laviano A., Meguid M.M., Gleason J.R., Yang Z.-J., and Oler A. Comparison of early feeding pattern dynamics in female and male rats after reversible ventromedial nucleus of hypothalamus block. J Investig Med 48 (2000) 417-4262
25. Cowley M.A., Cone R.D., Enriori P., Louiselle I., Williams S.M., and Evans A.E. Electrophysiological actions of peripheral hormones on melanocortin neurons. Ann N Y Acad Sci 994 (2003) 175-186
26. Marks D.L., and Cone R.D. The role of the melanocortin-3 receptor in cachexia. Ann N Y Acad Sci 994 (2003) 258-266
27. Cota D., Marsicano G., Tschöp M., Grübler Y., Flachskamm C., Schubert M., et al. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 112 (2003) 423-431
28. Zorilla E.P., Taché Y., and Koob G.F. Nibbling at the CRF receptor control of feeding and gastrointestinal motility. Trends Pharmacol Sci 24 (2003) 421-427
29. Goldsmith P.C., Boggan J.E., and Thind K.K. Opioid synapses on vasopressin neurons in the paraventricular and supraoptic nuclei of juvenile monkeys. Neuroscience 45 (1991) 709-719
30. Horvath T.L. Endocannabinoids and the regulation of body fat: the smoke is clearing. J Clin Invest 113 (2003) 323-326
31. Matias I., and Di Marzo V. Endocannabinoids and the control of energy balance. Trends Endocrinol Metab 18 (2007) 27-37
32. Di Marzo V., Goparahu S.K., Wang L., Liu J., Bátkai S., Járai Z., et al. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410 (2001) 822-825
33. ATP channel activation and leads to diet-sensitive obesity. J Clin Invest 116 (2006) 1886-1901
34. Low M.J., Hayward M.D., Appleyard S.M., and Rubinstein M. State-dependent modulation of feeding behavior by proopiomelanocortin-derived β-endorphin. Ann N Y Acad Sci 994 (2003) 192-201
35. Horton B.J., West C.E., and Turley S.D. Diurnal variation in the feeding pattern of guinea pigs. Nutr Metab 18 (1975) 294-301
36. Odumosu A. Vitamin C and weight reducing drugs on brain ascorbic acid in guinea pigs. Acta Vitaminol Enzymol 3 (1981) 96-102
37. Sherrill R.G., Berman J.M., Birkemo L., Croom D.K., Dezube M., Ervin G.N., et al. 1,4-Benzodiazepine peripheral cholecystokinin (CCK-A) receptor agonists. Bioorg Med Chem Lett 11 (2001) 1145-1148
38. + current in neurons of the mammalian hypothalamus. J Neurophysiol 94 (2005) 2983-2986
39. Ronnekleiv O.K., Loose M.D., Erickson K.R., and Kelly M.J. A method for immunocytochemical identification of biocytin-labeled neurons following intracellular recording. Biotechniques 9 (1990) 432-438
40. Weber E., Evans C.J., Chang J.-K., and Barchas J.D. Antibodies specific for α-N-acetyl-β-endorphins: radioimmunoassays and detection of acetylated β-endorphins in pituitary extracts. J Neurochem 38 (1982) 436-447
41. Cota D., Tschöp M.H., Horvath T.L., and Levine A.S. Cannabinoids, opioids and eating behavior: the molecular face of hedonism?. Brain Res Rev 51 (2006) 85-107
42. 2 receptors. Science 310 (2005) 329-332
43. Avraham Y., Menachem A.B., Okun A., Zlotarav O., Abel N., Mechoulam R., et al. Effects of the endocannabinoid noladin ether on body weight, food consumption, locomotor activity, and cognitive index in mice. Brain Res Bull 65 (2005) 117-123
44. Itateyama E., Chiba S., Sakata T., and Yoshimatsu H. Hypothalamic neuronal histamine in genetically obese animals: its implication of leptin action in the brain. Exp Biol Med 228 (2003) 1132-1137
45. Horvath T.L. The hardship of obesity: a soft-wired hypothalamus. Nat Neurosci 8 (2005) 561-565
46. Auclair N., Otani S., Soubrie P., and Crepel F. Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons. J Neurophysiol 83 (2000) 3287-3293
47. Shen M.X., Piser T.M., Seybold V.S., and Thayer S.A. Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J Neurosci 16 (1996) 4322-4334
48. Straiker A.J., Borden C.R., and Sullivan J.M. G-protein α subunit isoforms couple differentially to receptors that mediate presynaptic inhibition at rat hippocampal synapses. J Neurosci 22 (2002) 2460-2468
49. Vaughan C.W., Connor M., Bagley E.E., and Christie M.J. Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro. Mol Pharmacol 57 (2000) 288-295
50. Ohno-Shosaku T., Tsubokawa H., Mizushima I., Yoneda N., Zimmer A., and Kano M. Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses. J Neurosci 22 (2002) 3864-3872
51. Maejima T., Ohno-Shosaku T., and Kano M. Endogenous cannabinoid as a retrograde messenger from depolarized postsynaptic neurons to presynaptic terminals. Neurosci Res 40 (2001) 205-210
52. Melis M., Perra S., Muntoni A.L., Pillolla G., Lutz B., Marsicano G., et al. Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons. J Neurosci 24 (2004) 10707-10715
53. Di S., Malcher-Lopes R., Halmos K.C., and Tasker J.G. Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J Neurosci 23 (2003) 4850-4857
54. Hentges S.T., Low M.J., and Williams J.T. Differential regulation of synaptic inputs by constitutively released endocannabinoids and exogenous cannabinoids. J Neurosci 25 (2005) 9746-9751
55. Mackie K., Lai Y., Westenbroek R., and Mitchell R. Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J Neurosci 15 (1995) 6552-6561
56. Henry D.J., and Chavkin C. Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes. Neurosci Lett 186 (1995) 91-94
57. McAllister S.D., Griffin G., Satin L.S., and Abood M.E. Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a Xenopus oocyte expression system. J Pharmacol Exp Ther 291 (1999) 618-626
58. B receptor-mediated inhibition of GABAergic neurons in the arcuate nucleus. Neuroreport 10 (1999) 2681-2687
59. Wagner E.J., Rønnekleiv O.K., Bosch M.A., and Kelly M.J. Estrogen biphasically modifies hypothalamic GABAergic neuronal function concomitantly with negative and positive control of luteinizing hormone release. J Neurosci 21 (2001) 2085-2093
60. 3 dopamine autoreceptors do not activate G-protein-gated inwardly rectifying potassium channel currents in substantia nigra dopamine neurons. J Neurosci 23 (2003) 5693-5697
61. + conductance. J Physiol (Lond) 551 (2003) 295-308
62. Osei-Hyiaman D., Depetrillo M., Harvey-White J., Bannon A.W., Cravatt B.F., Kuhar M.J., et al. Cocaine- and amphetamine-related transcript is involved in the orexigenic effect of endogenous anandamide. Neuroendocrinology 81 (2005) 273-282
63. Yang Z.Y., Copolov D.L., and Lim A.T. Glutamate enhances the adenylyl cyclase-cAMP system-induced beta-endorphin secretion and POMC mRNA expression in rat hypothalamic neurons in culture: NMDA receptor-mediated modulation. Brain Res 692 (1995) 129-136
64. Appleyard S.M., Bailey T.W., Doyle M.W., Jin Y.-H., Smart J.L., Low M.J., et al. Proopiomelanocortin neurons in nucleus tractus solitarius are activated by visceral afferents: regulation by cholecystokinin and opioids. J Neurosci 25 (2005) 3578-3585
65. Gamber K.M., Macarthur H., and Westfall T.C. Cannabinoids augment the release of neuropeptide Y in the rat hypothalamus. Neuropharmacology 49 (2005) 646-652
66. Jo Y.-H., Chen Y.-J.L., Chua S.C., Talmage D.A., and Role L.W. Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit. Neuron 48 (2005) 1055-1066